Skip to main content
. 2015 Jan 22;9(3):1006–1012. doi: 10.3892/etm.2015.2204

Table I.

Post-transplantation treatment regimens.

Group Treatment (intraperitoneal)
Control NS
CXCL9 Ab and CXCL10 Ab CXCL9 Ab + CXCL10 Ab + NS
FTY720 FTY720 + NS
Combined CXCL9 Ab + CXCL10 Ab + FTY720 + NS

CXCL, C-X-C motif chemokine; Ab, antibody; NS, normal saline.